Claudia Lorena Salcido, PA-C

Claudia Salcido practices at Pacific Dermatology Institute in Redlands, California.

Claudia Salcido's NPI, 1821357955, was assigned on May 9, 2012. Claudia Salcido holds California license 22110.

Claudia Salcido's primary practice is Pacific Dermatology Institute, at 101 E Redlands Blvd, Redlands, CA 92373 in San Bernardino County. The practice phone is (951) 734-8989.

Claudia Salcido's primary practice is Pacific Dermatology Institute in Redlands, California. The medical group on file is Pacific Dermatology Institute.

Dmand AI tracks the electronic health record (EHR) system at each site where Claudia Salcido practices. Vendor and product names are available with a free account.

Physician assistant is Claudia Salcido's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Claudia Salcido is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Claudia Salcido is licensed in California.

CMS data shows 294 Medicare services from Claudia Salcido across 10 procedure codes in 2024, for 94 Medicare patients. Medicare paid $12,173 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Claudia Salcido in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 46% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Claudia Salcido's median patient age at 52, with 77% women.

In 2024, Claudia Salcido wrote 1,560 Medicare Part D claims for 577 patients. 91% of them were for generic drugs. CMS names the drug for 1,426 of them, across 27 drugs with 11 or more claims each, at $197,061 in total drug cost.

CMS Open Payments shows 135 general payments to Claudia Salcido from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. Sanofi and Genzyme US Companies paid the most, $651.